tRF5-Glu binds directly to a site in the 3′UTR of the breast cancer anti-estrogen resistance 3 (BCAR3) mRNA, downregulating its expression and inhibiting ovarian cancer cell proliferation [54]. Here, BCAR3 is linked to ovarian carcinoma.